BioInvent: New BI-1910 and BI-1206 data - Redeye
Bildkälla: Stockfoto

BioInvent: New BI-1910 and BI-1206 data - Redeye

Redeye comments on the new data from the triple combination study of BI-1206 and the phase I monotherapy data for BI-1910.

Redeye comments on the new data from the triple combination study of BI-1206 and the phase I monotherapy data for BI-1910.
Börsvärldens nyhetsbrev
ANNONSER